Studies on solubility enhancement of hydrophobic bioactive components by innovative techniques: Development of Nano based chemotherapeutic formulations

Pharmacology, Toxicology and Pharmaceutical Science

1. Nanoemulsion 100%
2. Bioactive Drug 89%
3. Bioavailability 73%
4. Surfactant 52%
5. Drug Delivery System 47%
6. Complexation 47%
7. Nanoparticle 42%
8. Cyclodextrin 42%
9. Pharmaceutics 31%
10. Anticancer Drug 26%
11. Nanocarrier 26%
12. Cosurfactant 26%
13. Malignant Neoplasm 21%
14. Dosage Form 21%
15. Drug Solubility 21%
16. Chemotherapy 15%
17. Microemulsion 15%
18. Excipient 10%
19. Clinical Trial 10%
20. Methyl Paraben 10%
21. Zeta Potential 10%
22. Drug Discovery 10%
23. Ezetimibe 10%
24. High Performance Liquid Chromatography 10%
25. Route of Administration 10%
26. Piroxicam 10%
27. Salt Formation 10%
28. Ibuprofen 10%
29. Lipophilicity 10%
30. Anticarcinogen 10%
31. Neoplasm 5%
32. Drug Carrier 5%
33. Solid Lipid Nanoparticle 5%
34. Mannitol 5%
35. Biological Activity 5%
36. Pharmacotherapy 5%
37. Structure Activity Relationship 5%
38. Felodipine 5%
39. Crystal Engineering 5%
40. Drug Action 5%
41. Liquid Formulation 5%
42. Diseases 5%
43. Polyvinyl Alcohol 5%
44. Eudragit 5%
45. Drug Formulation 5%
46. Nonionic Surfactant 5%
47. Thermostability 5%
48. Drug Concentration 5%
49. Therapeutic Effect 5%
50. Antioxidant Study 5%
51. Pharmacokinetic 5%
52. Crystallization 5%
53. Paclitaxel 5%
54. Particle-Size Distribution 5%
55. Deionized Water 5%
56. Micellar Solubilization 5%
57. Emulsifying Agent 5%
58. Methanol 5%
59. Isotopes of Potassium 5%
60. Cytotoxicity 5%
61. Side Effect 5%